Specialist and experienced pricing and market access consultancy
We will develop and implement a successful launch strategy for your product.
We build payer focussed pricing and market access strategies to enable commercial success.
We provide engaging training solutions that ensures your organisation stays ahead of the ever-changing market access landscape.
Unifying our internal strengths and external partnerships helps solve your pricing and market access challenges to drive patient access of your pharmaceutical products.
Clearly and concisely communicate key scientific, economic and commercial messages to enable company employees to effectively communicate the product’s value.
Individual solutions to suit you
We adapt our working style to reflect your needs
We have a wealth of practical knowledge & experience within the pharma industry & HTA bodies
We react quickly and effectively to provide the best support possible
There is no excerpt because this is a protected post.
Read moreThe population, intervention, comparator, and outcomes (PICO) element of the upcoming EU Joint Clini…
Read moreWe were thrilled to attend the World Evidence, Pricing and Access Congress (World EPA) in Amsterdam …
Read moreCharlie Hewitt from Remap Consulting initiated today’s session by providing a description of the c…
Read moreAUTHORS: Joyce Atim, Rahul Vadehra Rare diseases have a significant impact on people worldwide…
Read moreAUTHORS: Ella Odams, Richard Sloggett, Graham Foxon OBJECTIVES To evaluate if ChatGPT is a rel…
Read moreEU HTA Regulation goes live: A new era for HTA begins The much-awaited implementation of the r…
Read moreOur review of the 2024 pricing and market access revealed key challenges facing the pharmaceutical i…
Read moreIn January of this year, we summarized the key trends that our market access experts anticipated wou…
Read more